金河生物：2025年半年度净利润约1.38亿元 同比增加51.52%

Core Viewpoint - Jinhe Biological reported significant growth in its half-year performance for 2025, indicating strong operational momentum and profitability improvements [2] Financial Performance - The company's operating revenue for the first half of 2025 reached approximately 1.39 billion yuan, representing a year-on-year increase of 30.45% [2] - Net profit attributable to shareholders was around 138 million yuan, marking a year-on-year increase of 51.52% [2] - Basic earnings per share were reported at 0.1787 yuan, reflecting a year-on-year increase of 53.26% [2]